Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Hemostats Market by Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats), By Application (Prehospital Treatment, Hospital Treatment) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Hemostats Market by Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats), By Application (Prehospital Treatment, Hospital Treatment) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 194363 3300 Medical Devices & Consumables 377 233 Pages 4.6 (31)
                                          

The global hemostats market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of surgeries and rising incidence of cardiovascular diseases. The global hemostats market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into thrombi-based hemostats, oxidized regenerated cellulose based hemostats, combination hemostats, gelatine based hemostats and collagen based hemostats. On the basis of application it is segmented into prehospital treatment and hospital treatment. Geographically it has been classified into North America (US & Canada), Latin America (Mexico & Brazil), Europe (UK & Germany), Asia Pacific (China & Japan) and Middle East & Africa (Saudi Arabia).

Some Of The Growth Factors Of This Market:

  1. Increasing awareness about the benefits of hemostats over conventional methods such as sutures and stitches is also expected to fuel growth in this market during the forecast period.
  2. The rising geriatric population base across developed economies is also anticipated to boost demand for hemostats in the near future due to their ease-of-use and safety features when compared with conventional methods like sutures and stitches that require more skill on part of medical practitioners for successful application.

Industry Growth Insights published a new data on “Hemostats Market”. The research report is titled “Hemostats Market research by Types (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats), By Applications (Prehospital Treatment, Hospital Treatment), By Players/Companies Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Hemostats Market Research Report

By Type

Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats

By Application

Prehospital Treatment, Hospital Treatment

By Companies

Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Hemostats Industry Outlook


Global Hemostats Market Report Segments:

The global Hemostats market is segmented on the basis of:

Types

Thrombin-Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Prehospital Treatment, Hospital Treatment

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Ethicon
  2. Pfizer
  3. Baxter International Inc.
  4. C. R. Bard
  5. The Medicines Company
  6. Anika Therapeutics
  7. Advanced Medical Solutions
  8. Integra LifeSciences Corporation
  9. B Braun Melsungen AG
  10. Gelita Medical GmbH
  11. Equimedical
  12. Vascular Solutions
  13. Marine Polymer Technologies
  14. Z-Medica, LLC
  15. CryoLife
  16. BioCer Entwicklungs-GmbH.
  17. Biom'Up SAS

Global Hemostats Market Overview


Highlights of The Hemostats Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Thrombin-Based Hemostats
    2. Oxidized Regenerated Cellulose Based Hemostats
    3. Combination Hemostats
    4. Gelatin Based Hemostats
    5. Collagen Based Hemostats
  1. By Application:

    1. Prehospital Treatment
    2. Hospital Treatment
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hemostats Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Hemostats Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Hemostats are a type of medical device used to temporarily stop bleeding. They come in various shapes and sizes, including clamps, bandages, and tourniquets.

Some of the major players in the hemostats market are Ethicon, Pfizer, Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences Corporation, B Braun Melsungen AG, Gelita Medical GmbH, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, LLC, CryoLife, BioCer Entwicklungs-GmbH., Biom'Up SAS.

The hemostats market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Hemostats Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Hemostats Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Hemostats Market - Supply Chain
   4.5. Global Hemostats Market Forecast
      4.5.1. Hemostats Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Hemostats Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Hemostats Market Absolute $ Opportunity

5. Global Hemostats Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Hemostats Market Size and Volume Forecast by Type
      5.3.1. Thrombin-Based Hemostats
      5.3.2. Oxidized Regenerated Cellulose Based Hemostats
      5.3.3. Combination Hemostats
      5.3.4. Gelatin Based Hemostats
      5.3.5. Collagen Based Hemostats
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Hemostats Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Hemostats Market Size and Volume Forecast by Application
      6.3.1. Prehospital Treatment
      6.3.2. Hospital Treatment
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Hemostats Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Hemostats Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Hemostats Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Hemostats Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Hemostats Demand Share Forecast, 2019-2026

9. North America Hemostats Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Hemostats Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Hemostats Market Size and Volume Forecast by Application
      9.4.1. Prehospital Treatment
      9.4.2. Hospital Treatment
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Hemostats Market Size and Volume Forecast by Type
      9.7.1. Thrombin-Based Hemostats
      9.7.2. Oxidized Regenerated Cellulose Based Hemostats
      9.7.3. Combination Hemostats
      9.7.4. Gelatin Based Hemostats
      9.7.5. Collagen Based Hemostats
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Hemostats Demand Share Forecast, 2019-2026

10. Latin America Hemostats Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Hemostats Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Hemostats Market Size and Volume Forecast by Application
      10.4.1. Prehospital Treatment
      10.4.2. Hospital Treatment
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Hemostats Market Size and Volume Forecast by Type
      10.7.1. Thrombin-Based Hemostats
      10.7.2. Oxidized Regenerated Cellulose Based Hemostats
      10.7.3. Combination Hemostats
      10.7.4. Gelatin Based Hemostats
      10.7.5. Collagen Based Hemostats
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Hemostats Demand Share Forecast, 2019-2026

11. Europe Hemostats Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Hemostats Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Hemostats Market Size and Volume Forecast by Application
      11.4.1. Prehospital Treatment
      11.4.2. Hospital Treatment
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Hemostats Market Size and Volume Forecast by Type
      11.7.1. Thrombin-Based Hemostats
      11.7.2. Oxidized Regenerated Cellulose Based Hemostats
      11.7.3. Combination Hemostats
      11.7.4. Gelatin Based Hemostats
      11.7.5. Collagen Based Hemostats
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. arket Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Hemostats Demand Share, 2019-2026

12. Asia Pacific Hemostats Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Hemostats Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Hemostats Market Size and Volume Forecast by Application
      12.4.1. Prehospital Treatment
      12.4.2. Hospital Treatment
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Hemostats Market Size and Volume Forecast by Type
      12.7.1. Thrombin-Based Hemostats
      12.7.2. Oxidized Regenerated Cellulose Based Hemostats
      12.7.3. Combination Hemostats
      12.7.4. Gelatin Based Hemostats
      12.7.5. Collagen Based Hemostats
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Hemostats Demand Share, 2019-2026

13. Middle East & Africa Hemostats Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Hemostats Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Hemostats Market Size and Volume Forecast by Application
      13.4.1. Prehospital Treatment
      13.4.2. Hospital Treatment
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Hemostats Market Size and Volume Forecast by Type
      13.7.1. Thrombin-Based Hemostats
      13.7.2. Oxidized Regenerated Cellulose Based Hemostats
      13.7.3. Combination Hemostats
      13.7.4. Gelatin Based Hemostats
      13.7.5. Collagen Based Hemostats
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Hemostats Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Hemostats Market: Market Share Analysis
   14.2. Hemostats Distributors and Customers
   14.3. Hemostats Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Ethicon
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Pfizer
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Baxter International Inc.
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. C. R. Bard
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. The Medicines Company
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Anika Therapeutics
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Advanced Medical Solutions
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Integra LifeSciences Corporation
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. B Braun Melsungen AG
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Gelita Medical GmbH
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Equimedical
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Vascular Solutions
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Marine Polymer Technologies
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Z-Medica, LLC
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. CryoLife
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. BioCer Entwicklungs-GmbH.
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. Biom'Up SAS
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us